Clinical Trial Search block Test
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients with Migraine - PIONEER-PEDS2
LAHW_Pioneer_2
What is the goal of the study?
To learn more about this study, please email the study team member listed below.
Who can participate in the study?
Everyone